Covid-19 Drug Racket: Pharma firm MD and 7 others busted

HYDERABAD: A Pharma firm MD and 7 othersin Hyderabad who were Black-marketing the covid-19 drugs were arrested by the Task Force. A chain of middlemen was used by the gang to supply drugs to patients.

K Venkata Subramanyam alias Phani, the MD of Sri Medicure Products (OPC) Private Limited, revealed that he procured drugs like Remdesivir and FabiFlu from the Hetero Pharma unit in Sangareddy district.

A drug, Tocilizumab, was also procured through Gagan Khurana (21), a Delhi- based supplier. Whatsapp platform was used by the gang and the business was running from past one month. The gang also accepted cash and UPI payment. “Drugs worth Rs 35 were seized from their possession”, according to Hyderabad Police Commissioner Anjani Kumar.
Police further said that, “K Venkata Subramanyam used to sold the drug first to Santosh Kumar. Afterwards, it changed many people till it reached the client. A margin of around Rs 4,000 were kept by each person. Inquiries also revealed that Remdesivir is available at Rs 5,400 per unit, but the gang members used to sale it for around Rs 40,000 and Tocilizumab which costs Rs 40,000 per unit, was being sold for more than Rs 1 lakh.

These drug is used to treat Covid-19 patients who are in the ventilator stage. Several patients who purchased the drug from the gang have been recovered. who Supplier of Tocilizumab to Phani, Gagan Khurana flew away to the city to deliver the medicines when he was arrested. Police officials are further investigating whether the gang supplied drugs in neighboring states as well.

  • Related Posts

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    The inspection revealed incomplete manufacturing records, poor hygiene, inadequate quality-control systems and the omission of ingredients specified in approved Ayurvedic formulations. The Maharashtra Food and Drug Administration (FDA) on Thursday…

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Amneal Pharmaceuticals, Inc. announced the completion of its acquisition of Kashiv BioSciences, LLC, creating a fully integrated global biosimilars leader with end-to-end capabilities across research, development, manufacturing and commercialization. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    NHS backs delayed‑release treatment for cystinosis

    NHS backs delayed‑release treatment for cystinosis